Advanced Lung Cancer Clinical Trials

15 recruiting

Advanced Lung Cancer Trials at a Glance

15 actively recruiting trials for advanced lung cancer are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Phase 1 with 7 trials, with the heaviest enrollment activity in Hangzhou, Los Angeles, and Boston. Lead sponsors running advanced lung cancer studies include Chongqing Precision Biotech Co., Ltd, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, and BioNTech SE.

Browse advanced lung cancer trials by phase

Treatments under study

About Advanced Lung Cancer Clinical Trials

Looking for clinical trials for Advanced Lung Cancer? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Advanced Lung Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Advanced Lung Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 1Phase 2

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Advanced Lung Cancer
BioNTech SE594 enrolled58 locationsNCT06892548
Recruiting
Phase 1

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Metastatic Breast CancerAdvanced Breast CancerMetastatic Lung Cancer+6 more
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)392 enrolled36 locationsNCT06625775
Recruiting
Not Applicable

A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors

Advanced Lung CancerPhysical Function
Massachusetts General Hospital250 enrolled1 locationNCT07227623
Recruiting
Not Applicable

Engage Psychosocial Intervention for Cancer Symptoms

Advanced Breast CancerAdvanced Prostate CancerAdvanced Lung Cancer+2 more
Duke University190 enrolled1 locationNCT06555588
Recruiting
Not Applicable

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

Advanced Breast CancerEarly Breast CancerAdvanced Lung Cancer+5 more
Ulsan University Hospital414 enrolled5 locationsNCT07405931
Recruiting
Early Phase 1

Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.

Advanced Lung CancerLung Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences83 enrolled1 locationNCT06928922
Recruiting
Phase 1Phase 2

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer

Advanced Lung Cancer
Minghui Pharmaceutical (Hangzhou) Ltd300 enrolled1 locationNCT07229599
Recruiting
Phase 1

Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer

Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd60 enrolled1 locationNCT06945523
Recruiting
Phase 1

Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd60 enrolled1 locationNCT06992583
Recruiting
Phase 1

Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma

Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd60 enrolled1 locationNCT06903117
Recruiting
Phase 1

A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer

Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd48 enrolled1 locationNCT06768151
Recruiting

A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer

Advanced Lung Cancer
Hunan Province Tumor Hospital200 enrolled1 locationNCT06183762
Recruiting
Early Phase 1

EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer

EGFR/ B7H3-positive Advanced Lung CancerEGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
Second Affiliated Hospital of Guangzhou Medical University30 enrolled1 locationNCT05341492
Recruiting
Early Phase 1

WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody

Advanced Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University20 enrolled1 locationNCT06106152
Recruiting

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

SarcopeniaAdvanced Lung Cancer
Prince of Songkla University240 enrolled1 locationNCT06326086